---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-241556"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2025-10-16T23:59:59+00:00"
generated_at: "2026-05-17T03:34:11.805586+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Iterum files $20M ATM offering; ORLYNVAH launched Aug 2025 with modest sales expected

## Summary
- Filed prospectus supplement for ATM offering of up to $20M aggregate gross proceeds (max ~21.8M ordinary shares).
- Previously raised approximately $36.2M under same Sales Agreement with H.C. Wainwright.
- ORLYNVAH commercially launched in U.S. in August 2025; company expects modest sales in 2025.

## SEC filing metadata
- accession: 0001193125-25-241556
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2025-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000119312525241556/0001193125-25-241556-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000119312525241556/d933718d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-241556
- JSON: https://secwatch.observer/filing/0001193125-25-241556.json
- Plain text: https://secwatch.observer/filing/0001193125-25-241556.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.